Alzheimer's & Dementia: Translational Research & Clinical Interventions - Volume 2 - Issue 3 

Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women

Fulltext Access 7 Pages 2016

First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease

Fulltext Access 8 Pages 2016

Proof of concept demonstration of optimal composite MRI endpoints for clinical trials

Fulltext Access 5 Pages 2016

B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?

Fulltext Access 6 Pages 2016

NPT088 reduces both amyloid-β and tau pathologies in transgenic mice

Fulltext Access 15 Pages 2016

Quantile regression to characterize solanezumab effects in Alzheimer's disease trials

Fulltext Access 7 Pages 2016

Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor

Fulltext Access 11 Pages 2016

Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease

Fulltext Access 10 Pages 2016